The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIL0A.L Regulatory News (IL0A)

  • There is currently no data for IL0A

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Supervisory Review & Evaluation Process Update

21 Dec 2016 15:00

RNS Number : 5161S
Permanent TSB Group Holdings PLC
21 December 2016
 

21 December 2016

 

PERMANENT TSB GROUP HOLDINGS PLC

 

2016 Supervisory Review and Evaluation Process - Update

 

The Group announced the outcome of the 2016 Supervisory Review and Evaluation Process ("SREP") on 13 December 2016. The announcement detailed the Group's SREP capital requirement set by the European Central Bank which will be effective from 1 January 2017.

 

The Group disclosed that the CET 1 ratio of 9.2% consisted of a Pillar 1 Capital Requirements Regulation ("CRR") requirement of 4.50%, a Pillar 2 Requirement ("P2R") of 3.45% and a Capital Conservation Buffer ("CCB") of 1.25%. Pillar 2 Guidance ("P2G") was not publicly disclosed at that time under the advice of the European Central Bank.

 

However, noting the disclosure of P2G by another European bank recently, the Group feels obliged to disclose its P2G for the benefit of shareholders. In that context, P2G for the Group is set at 2.25% effective from 1 January 2017 to be held in the form of Common Equity Tier 1 capital.

 

Along with the SREP capital requirements, Pillar 2 Guidance is also subject to annual review.

 

Ends

 

For further information, please contact:

 

Patricia Carroll

Interim Group Chief Financial Officer

patricia.carroll@permanenttsb.ie

+353 1 669 5354

Rajesh ManirajanHead of Investor Relationsrajesh.manirajan@permanenttsb.ie+353 1 669 5622

Ray GordonGordon MRMptsb@gordonmrm.ie+353 87 241 7373

 

 

Note on forward-looking information:

This Announcement contains forward-looking statements, which are subject to risks and uncertainties because they relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Group or the industry in which it operates, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements referred to in this paragraph speak only as at the date of this Announcement. The Group undertakes no obligation to release publicly any revision or updates to these forward-looking statements to reflect future events, circumstances, unanticipated events, new information or otherwise except as required by law or by any appropriate regulatory authority.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRAKDDPQBDDOBB
Date   Source Headline
26th Nov 20203:30 pmRNSDirectorate Change
25th Nov 20202:22 pmRNSStabilisation Notice
18th Nov 20209:10 amRNSStabilisation Notice
3rd Nov 20207:00 amRNSTrading Statement
27th Oct 20207:00 amRNSSale of Buy To Let Loan Portfolio
12th Oct 20202:00 pmRNSDirector Declaration
29th Sep 20204:30 pmRNSAppointment of Senior Independent Director
25th Sep 202010:00 amRNSAppointment of Interim CFO
12th Aug 20204:00 pmRNSDirector/PDMR Shareholding
5th Aug 20203:00 pmRNSDirectorate Change
5th Aug 20203:00 pmRNSResult of AGM
4th Aug 20207:00 amRNSCommentary on Half-Year Report
4th Aug 20207:00 amRNSHalf-year Report
6th Jul 202012:00 pmRNSEuronext Listing Rules 6.1.82(1) & (2) Disclosure
6th Jul 202012:00 pmRNSNotice of AGM
22nd Jun 202010:00 amRNSAppointment of Chief Executive Officer
14th May 20207:00 amRNSTrading Statement
20th Mar 202012:00 pmRNSConvening of Annual General Meeting Deferred
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
26th Feb 20207:00 amRNSCommentary on Annual Financial Report
26th Feb 20207:00 amRNSAnnual Financial Report
24th Feb 20204:41 pmRNSSecond Price Monitoring Extn
24th Feb 20204:37 pmRNSPrice Monitoring Extension
28th Jan 20204:00 pmRNSDirectorate Change
6th Nov 20197:00 amRNSTrading Statement
29th Oct 20194:00 pmRNSDirector Declaration
29th Oct 20193:00 pmRNSDirectorate Change
24th Oct 20192:00 pmRNSChief Executive To Step Down During 2020
2nd Oct 201910:00 amRNSDirector Declaration
26th Sep 201912:27 pmRNSStabilisation Notice
24th Sep 20193:30 pmRNSDirectorate Changes
19th Sep 20195:00 pmRNSDirector Declaration
19th Sep 201911:17 amRNSStabilisation Notice
12th Sep 20192:00 pmRNSSale of Non-Performing Loan Portfolio
3rd Sep 201911:00 amRNSDirector/PDMR Shareholding
3rd Sep 201911:00 amRNSDirector/PDMR Shareholding
6th Aug 20194:00 pmRNSDirector/PDMR Shareholding
29th Jul 201910:00 amRNSDirector/PDMR Shareholding
29th Jul 201910:00 amRNSDirector/PDMR Shareholding
26th Jul 20195:00 pmRNSHalf-year Report
25th Jul 20197:00 amRNSHalf-year Report
25th Jul 20197:00 amRNS2019 Half Year Report Commentary
30th May 20192:00 pmRNSConclusion of Tracker Enforcement Investigation
14th May 20194:30 pmRNSResult of AGM
9th May 20197:00 amRNSTrading Update
29th Mar 20193:30 pmRNSNotice of AGM
27th Feb 20197:00 amRNSAnnual Financial Report
27th Feb 20197:00 amRNS2018 Full Year Report Commentary
29th Nov 20184:00 pmRNSSecuritisation of a Non-Performing Loan Portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.